91 related articles for article (PubMed ID: 2205130)
1. Effect of cardiopulmonary bypass on plasma levels of nifedipine.
Katz RI; Kanchuger MS; Patton KF; Eide TR
Anesth Analg; 1990 Oct; 71(4):411-4. PubMed ID: 2205130
[TBL] [Abstract][Full Text] [Related]
2. The calcium channel blocker nifedipine fails to inhibit leucocyte elastase release during cardiopulmonary bypass.
Massaut J; Hennebert N; Tasiaux N; Demanet H
Acta Anaesthesiol Scand; 1993 Jan; 37(1):82-4. PubMed ID: 8424302
[TBL] [Abstract][Full Text] [Related]
3. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass.
Lehmann LE; Schroeder S; Hartmann W; Dewald O; Book M; Weber SU; Schewe JC; Stüber F
Eur J Cardiothorac Surg; 2006 Jul; 30(1):59-63. PubMed ID: 16527487
[TBL] [Abstract][Full Text] [Related]
4. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?
Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R
Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545
[TBL] [Abstract][Full Text] [Related]
5. The effect of sublingual nifedipine on coronary venous graft resistance immediately following cardiopulmonary bypass.
Eide TR; Katz RI; Poppers PJ
Anesth Analg; 1989 Apr; 68(4):462-6. PubMed ID: 2929979
[TBL] [Abstract][Full Text] [Related]
6. [Nifedipine versus nitroglycerin in aortocoronary bypass surgery. The effect on hemodynamics, kidney function and homologous blood requirement].
Petry A; Wulf H; Blömer U; Wawersik J
Anaesthesist; 1992 Jan; 41(1):39-46. PubMed ID: 1536439
[TBL] [Abstract][Full Text] [Related]
7. Mini-circuit cardiopulmonary bypass with vacuum assisted venous drainage: feasibility of an asanguineous prime in the neonate.
Lau CL; Posther KE; Stephenson GR; Lodge A; Lawson JH; Darling EM; Davis RD; Ungerleider RM; Jaggers J
Perfusion; 1999 Sep; 14(5):389-96. PubMed ID: 10499656
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.
Davis R; Whittington R
Drugs; 1995 Jun; 49(6):954-83. PubMed ID: 7543841
[TBL] [Abstract][Full Text] [Related]
9. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.
Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E
Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary bypass prime composition: beyond crystalloids versus colloids.
Malmqvist G; Claesson Lingehall H; Appelblad M; Svenmarker S
Perfusion; 2019 Mar; 34(2):130-135. PubMed ID: 30114960
[TBL] [Abstract][Full Text] [Related]
11. Circulating and Urinary miR-210 and miR-16 Increase during Cardiac Surgery Using Cardiopulmonary Bypass - A Pilot Study.
Mazzone AL; Baker RA; McNicholas K; Woodman RJ; Michael MZ; Gleadle JM
J Extra Corpor Technol; 2018 Mar; 50(1):19-29. PubMed ID: 29559751
[TBL] [Abstract][Full Text] [Related]
12. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass.
Blume ED; Nelson DP; Gauvreau K; Walsh AZ; Plumb C; Neufeld EJ; Hickey PR; Mayer JE; Newburger JW
Circulation; 1997 Nov; 96(9 Suppl):II-352-7. PubMed ID: 9386123
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ulinastatin on coagulation and platelet function in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass].
Ji HW; Chen L
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):175-8. PubMed ID: 19537033
[TBL] [Abstract][Full Text] [Related]
14. Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass.
Qin C; Gu J; Hu J; Qian H; Fei X; Li Y; Liu R; Meng W
J Cardiothorac Surg; 2016 Jun; 11(1):90. PubMed ID: 27266529
[TBL] [Abstract][Full Text] [Related]
15. Plasma-Lyte 148 vs. Hartmann's solution for cardiopulmonary bypass pump prime: a prospective double-blind randomized trial.
Weinberg L; Chiam E; Hooper J; Liskaser F; Hawkins AK; Massie D; Ellis A; Tan CO; Story D; Bellomo R
Perfusion; 2018 May; 33(4):310-319. PubMed ID: 29144182
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.
Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G
J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508
[TBL] [Abstract][Full Text] [Related]
17. [Myocardial protective effect of ulinastatin against ischemia/reperfusion injury during open heart surgery with cardiopulmonary bypass].
Ren TY; Yang XW; Ma Y; Wang F; Qiang WD
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1391-3. PubMed ID: 14521739
[TBL] [Abstract][Full Text] [Related]
18. Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine.
Cziráki A; Ajtay Z; Németh Á; Lenkey Z; Sulyok E; Szabados S; Alotti N; Martens-Lobenhoffer J; Szabó C; Bode-Böger SM
Coron Artery Dis; 2011 Jun; 22(4):245-52. PubMed ID: 21383621
[TBL] [Abstract][Full Text] [Related]
19. Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.
Cugno M; Nussberger J; Biglioli P; Alamanni F; Coppola R; Agostoni A
Chest; 2001 Dec; 120(6):1776-82. PubMed ID: 11742901
[TBL] [Abstract][Full Text] [Related]
20. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
